Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Ecotoxicological Test Assay Using OECD TG 212 in Marine Java Medaka (Oryzias javanicus) and Freshwater Japanese Medaka (Oryzias latipes).

Horie Y, Kanazawa N, Yamagishi T, Yonekura K, Tatarazako N.

Bull Environ Contam Toxicol. 2018 Jul 18. doi: 10.1007/s00128-018-2398-1. [Epub ahead of print]

PMID:
30022344
2.

Sézary syndrome in an anti-human T-cell lymphotropic virus type 1 seropositive carrier.

Baba N, Fujii K, Nomoto Y, Jimura N, Higashi Y, Takami S, Masamoto I, Yonekura K, Mera K, Kanekura T.

J Dermatol. 2018 Jun 28. doi: 10.1111/1346-8138.14522. [Epub ahead of print] No abstract available.

PMID:
29952024
3.

CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Sakamoto Y, Ishida T, Masaki A, Murase T, Yonekura K, Tashiro Y, Tokunaga M, Utsunomiya A, Ito A, Kusumoto S, Iida S, Ueda R, Inagaki H.

Blood. 2018 Jun 21. pii: blood-2018-02-835991. doi: 10.1182/blood-2018-02-835991. [Epub ahead of print] No abstract available.

PMID:
29930010
4.

Hopkins syndrome following the first episode of bronchial asthma associated with enterovirus D68: a case report.

Hayashi F, Hayashi S, Matsuse D, Yamasaki R, Yonekura K, Kira JI.

BMC Neurol. 2018 May 23;18(1):71. doi: 10.1186/s12883-018-1075-7.

5.

Ionic scattering factors of atoms that compose biological molecules.

Yonekura K, Matsuoka R, Yamashita Y, Yamane T, Ikeguchi M, Kidera A, Maki-Yonekura S.

IUCrJ. 2018 Apr 27;5(Pt 3):348-353. doi: 10.1107/S2052252518005237. eCollection 2018 May 1.

6.

TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations.

Hasako S, Terasaka M, Abe N, Uno T, Ohsawa H, Hashimoto A, Fujita R, Tanaka K, Okayama T, Wadhwa R, Miyadera K, Aoyagi Y, Yonekura K, Matsuo K.

Mol Cancer Ther. 2018 May 10. doi: 10.1158/1535-7163.MCT-17-1206. [Epub ahead of print]

PMID:
29748209
7.

Correction: Hexameric and pentameric complexes of the ExbBD energizer in the Ton system.

Yonekura K, Maki-Yonekura S, Matsuoka R, Yamashita Y, Shimizu H, Tanaka M, Iwabuki F.

Elife. 2018 May 4;7. pii: e37833. doi: 10.7554/eLife.37833. No abstract available.

8.

Hexameric and pentameric complexes of the ExbBD energizer in the Ton system.

Maki-Yonekura S, Matsuoka R, Yamashita Y, Shimizu H, Tanaka M, Iwabuki F, Yonekura K.

Elife. 2018 Apr 17;7. pii: e35419. doi: 10.7554/eLife.35419. Erratum in: Elife. 2018 May 04;7:.

9.

Indium-Catalyzed Annulation of o-Acylanilines with Alkoxyheteroarenes: Synthesis of Heteroaryl[b]quinolines and Subsequent Transformation to Cryptolepine Derivatives.

Yonekura K, Shinoda M, Yonekura Y, Tsuchimoto T.

Molecules. 2018 Apr 5;23(4). pii: E838. doi: 10.3390/molecules23040838.

10.

[A Case of Non-Functioning Pancreatic Neuroendocrine Tumor Accompanied by Stenosis of the Main Pancreatic Duct].

Ishii T, Nakamura N, Saitou T, Yonekura K, Watanabe Y, Sanada T, Kuwabara H, Goseki N, Koike M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1632-1634. Review. Japanese.

PMID:
29394725
11.

[A Case of Extrarenal Retroperitoneal Angiomyolipoma].

Saito T, Watanabe Y, Ishii T, Yonekura K, Sanada T, Kuwabara H, Nakamura N, Goseki N.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1346-1348. Review. Japanese.

PMID:
29394629
12.

Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.

Obata Y, Horikawa K, Shiina I, Takahashi T, Murata T, Tasaki Y, Suzuki K, Yonekura K, Esumi H, Nishida T, Abe R.

Cancer Lett. 2018 Feb 28;415:1-10. doi: 10.1016/j.canlet.2017.11.032. Epub 2017 Nov 28.

13.

Fukushima Triple Disaster and the Road to Recovery: a Qualitative Exploration of Resilience in Internally Displaced Residents.

Mann CL, Gillezeau CN, Massazza A, Lyons DJ, Tanaka K, Yonekura K, Sekine H, Yanagisawa R, Katz CL.

Psychiatr Q. 2018 Jun;89(2):383-397. doi: 10.1007/s11126-017-9542-7.

PMID:
29079958
14.

Derivation of the Time-Reversal Anomaly for (2+1)-Dimensional Topological Phases.

Tachikawa Y, Yonekura K.

Phys Rev Lett. 2017 Sep 15;119(11):111603. doi: 10.1103/PhysRevLett.119.111603. Epub 2017 Sep 13.

PMID:
28949209
15.

Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.

Tokunaga M, Yonekura K, Nakamura D, Haraguchi K, Tabuchi T, Fujino S, Hayashida M, Maekawa K, Arai A, Nakano N, Kamada Y, Kubota A, Inoue H, Owatari S, Takeuchi S, Takatsuka Y, Otsuka M, Hanada S, Matsumoto T, Yoshimitsu M, Ishitsuka K, Utsunomiya A.

Br J Haematol. 2018 May;181(4):539-542. doi: 10.1111/bjh.14634. Epub 2017 Apr 3. No abstract available.

PMID:
28369823
16.

[Resection of Pancreatic Metastasis from Renal Cell Carcinoma 21 Years after Nephrectomy].

Miura T, Nakamura N, Ogawa K, Watanabe Y, Yonekura K, Sanada T, Kuwabara H, Goseki N.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2187-2189. Review. Japanese.

PMID:
28133264
17.

Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sections.

Kato J, Masaki A, Fujii K, Takino H, Murase T, Yonekura K, Utsunomiya A, Ishida T, Iida S, Inagaki H.

Pathol Int. 2016 Nov;66(11):618-621. doi: 10.1111/pin.12462. Epub 2016 Sep 27.

PMID:
27678343
18.

High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.

Fujita H, Gomori A, Fujioka Y, Kataoka Y, Tanaka K, Hashimoto A, Suzuki T, Ito K, Haruma T, Yamamoto-Yokoi H, Harada N, Sakuragi M, Oda N, Matsuo K, Inada M, Yonekura K.

PLoS One. 2016 Oct 13;11(10):e0164830. doi: 10.1371/journal.pone.0164830. eCollection 2016.

19.

Phase I/II study of the oral retinoid X receptor agonist bexarotene in Japanese patients with cutaneous T-cell lymphomas.

Hamada T, Sugaya M, Tokura Y, Ohtsuka M, Tsuboi R, Nagatani T, Tani M, Setoyama M, Matsushita S, Kawai K, Yonekura K, Yoshida T, Saida T, Iwatsuki K.

J Dermatol. 2017 Feb;44(2):135-142. doi: 10.1111/1346-8138.13542. Epub 2016 Aug 20.

PMID:
27543197
20.

The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.

Watanabe K, Hirata M, Tominari T, Matsumoto C, Fujita H, Yonekura K, Murphy G, Nagase H, Miyaura C, Inada M.

J Biol Chem. 2016 Sep 30;291(40):20891-20899. Epub 2016 Aug 18.

21.

Search for a Minimal N=1 Superconformal Field Theory in 4D.

Xie D, Yonekura K.

Phys Rev Lett. 2016 Jul 1;117(1):011604. doi: 10.1103/PhysRevLett.117.011604. Epub 2016 Jul 1.

PMID:
27419561
22.

Taste substance binding elicits conformational change of taste receptor T1r heterodimer extracellular domains.

Nango E, Akiyama S, Maki-Yonekura S, Ashikawa Y, Kusakabe Y, Krayukhina E, Maruno T, Uchiyama S, Nuemket N, Yonekura K, Shimizu M, Atsumi N, Yasui N, Hikima T, Yamamoto M, Kobayashi Y, Yamashita A.

Sci Rep. 2016 May 10;6:25745. doi: 10.1038/srep25745.

23.

Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma.

Yonekura K, Tokunaga M, Kawakami N, Takeda K, Kanzaki T, Nakano N, Kubota A, Takeuchi S, Takatsuka Y, Seto M, Utsunomiya A.

Acta Derm Venereol. 2016 Nov 2;96(7):1000-1002. doi: 10.2340/00015555-2421. No abstract available.

24.

Cryogenic coherent X-ray diffraction imaging of biological samples at SACLA: a correlative approach with cryo-electron and light microscopy.

Takayama Y, Yonekura K.

Acta Crystallogr A Found Adv. 2016 Mar;72(Pt 2):179-89. doi: 10.1107/S2053273315023980. Epub 2016 Jan 29.

PMID:
26919369
25.

Cosmologically Safe QCD Axion without Fine-Tuning.

Yamada M, Yanagida TT, Yonekura K.

Phys Rev Lett. 2016 Feb 5;116(5):051801. doi: 10.1103/PhysRevLett.116.051801. Epub 2016 Feb 5.

PMID:
26894701
26.

[A Case of Brain Metastases from Pancreatic Cancer That Had Been Treated Effectively with FOLFIRINOX].

Miura T, Nakamura N, Kurihara Y, Yonekura K, Watanabe Y, Sanada T, Kuwabara H, Goseki N.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2357-9. Review. Japanese.

PMID:
26805363
27.

Darier's Disease with Esophageal Involvement.

Baba A, Yonekura K, Takeda K, Kawai K, Kanekura T.

Acta Dermatovenerol Croat. 2015;23(3):218-9. No abstract available.

PMID:
26476908
28.

A Comparative Study Between Deep Inferior Epigastric Artery Perforator and Thoracoacromial Venous Supercharged Deep Inferior Epigastric Artery Perforator Flaps.

Ayestaray B, Yonekura K, Motomura H, Ziade M.

Ann Plast Surg. 2016 Jan;76(1):78-82. doi: 10.1097/SAP.0000000000000581.

PMID:
26207537
29.

Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.

Yonekura K, Utsunomiya A, Seto M, Takatsuka Y, Takeuchi S, Tokunaga M, Kubota A, Takeda K, Kanzaki T, Uchida Y, Kawai K, Kanekura T.

J Dermatol. 2015 Dec;42(12):1143-8. doi: 10.1111/1346-8138.13004. Epub 2015 Jun 30.

PMID:
26134467
30.

[A case of cardiac tamponade due to pericarditis carcinomatosa of breast cancer successfully treated via pericardiocentesis and systemic chemo-endocrine therapy].

Satoh E, Ebuchi M, Suzuki K, Uehira D, Ono S, Yonekura K, Murakata A, Tanami H, Maruyama S, Sugano N, Maruyama M, Matsumoto J, Sakoma T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1895-6. Japanese.

PMID:
25731367
31.

Electron crystallography of ultrathin 3D protein crystals: atomic model with charges.

Yonekura K, Kato K, Ogasawara M, Tomita M, Toyoshima C.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3368-73. doi: 10.1073/pnas.1500724112. Epub 2015 Feb 17.

32.

Signal enhancement and Patterson-search phasing for high-spatial-resolution coherent X-ray diffraction imaging of biological objects.

Takayama Y, Maki-Yonekura S, Oroguchi T, Nakasako M, Yonekura K.

Sci Rep. 2015 Jan 28;5:8074. doi: 10.1038/srep08074.

33.

TAS-116, a highly selective inhibitor of heat shock protein 90α and β, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models.

Ohkubo S, Kodama Y, Muraoka H, Hitotsumachi H, Yoshimura C, Kitade M, Hashimoto A, Ito K, Gomori A, Takahashi K, Shibata Y, Kanoh A, Yonekura K.

Mol Cancer Ther. 2015 Jan;14(1):14-22. doi: 10.1158/1535-7163.MCT-14-0219. Epub 2014 Nov 21.

34.

Changes in dermal papilla structures due to aging in the facial cheek region.

Mizukoshi K, Yonekura K, Futagawa M, Nakamura T, Hirayama K, Takahashi K.

Skin Res Technol. 2015 May;21(2):224-31. doi: 10.1111/srt.12180. Epub 2014 Aug 23.

PMID:
25156803
35.

Crisis of Japanese vascular flora shown by quantifying extinction risks for 1618 taxa.

Kadoya T, Takenaka A, Ishihama F, Fujita T, Ogawa M, Katsuyama T, Kadono Y, Kawakubo N, Serizawa S, Takahashi H, Takamiya M, Fujii S, Matsuda H, Muneda K, Yokota M, Yonekura K, Yahara T.

PLoS One. 2014 Jun 12;9(6):e98954. doi: 10.1371/journal.pone.0098954. eCollection 2014.

36.

Single-shot three-dimensional structure determination of nanocrystals with femtosecond X-ray free-electron laser pulses.

Xu R, Jiang H, Song C, Rodriguez JA, Huang Z, Chen CC, Nam D, Park J, Gallagher-Jones M, Kim S, Kim S, Suzuki A, Takayama Y, Oroguchi T, Takahashi Y, Fan J, Zou Y, Hatsui T, Inubushi Y, Kameshima T, Yonekura K, Tono K, Togashi T, Sato T, Yamamoto M, Nakasako M, Yabashi M, Ishikawa T, Miao J.

Nat Commun. 2014 Jun 5;5:4061. doi: 10.1038/ncomms5061.

PMID:
24898682
37.

Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.

Nakade J, Takeuchi S, Nakagawa T, Ishikawa D, Sano T, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, Matsumoto K, Yonekura K, Yano S.

J Thorac Oncol. 2014 Jun;9(6):775-83. doi: 10.1097/JTO.0000000000000170.

38.

Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.

Yonekura K, Kanzaki T, Gunshin K, Kawakami N, Takatsuka Y, Nakano N, Tokunaga M, Kubota A, Takeuchi S, Kanekura T, Utsunomiya A.

J Dermatol. 2014 Mar;41(3):239-44. doi: 10.1111/1346-8138.12419.

PMID:
24628073
39.

Post-transcriptional regulator Hfq binds catalase HPII: crystal structure of the complex.

Yonekura K, Watanabe M, Kageyama Y, Hirata K, Yamamoto M, Maki-Yonekura S.

PLoS One. 2013 Nov 6;8(11):e78216. doi: 10.1371/journal.pone.0078216. eCollection 2013.

40.

The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile.

Fujita H, Miyadera K, Kato M, Fujioka Y, Ochiiwa H, Huang J, Ito K, Aoyagi Y, Takenaka T, Suzuki T, Ito S, Hashimoto A, Suefuji T, Egami K, Kazuno H, Suda Y, Nishio K, Yonekura K.

Mol Cancer Ther. 2013 Dec;12(12):2685-96. doi: 10.1158/1535-7163.MCT-13-0459. Epub 2013 Oct 18.

41.

Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.

Staals RHJ, Agari Y, Maki-Yonekura S, Zhu Y, Taylor DW, van Duijn E, Barendregt A, Vlot M, Koehorst JJ, Sakamoto K, Masuda A, Dohmae N, Schaap PJ, Doudna JA, Heck AJR, Yonekura K, van der Oost J, Shinkai A.

Mol Cell. 2013 Oct 10;52(1):135-145. doi: 10.1016/j.molcel.2013.09.013.

42.

Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.

Zhao L, Yasumoto K, Kawashima A, Nakagawa T, Takeuchi S, Yamada T, Matsumoto K, Yonekura K, Yoshie O, Yano S.

Cancer Sci. 2013 Dec;104(12):1640-6. doi: 10.1111/cas.12301. Epub 2013 Nov 13.

43.

KOTOBUKI-1 apparatus for cryogenic coherent X-ray diffraction imaging.

Nakasako M, Takayama Y, Oroguchi T, Sekiguchi Y, Kobayashi A, Shirahama K, Yamamoto M, Hikima T, Yonekura K, Maki-Yonekura S, Kohmura Y, Inubushi Y, Takahashi Y, Suzuki A, Matsunaga S, Inui Y, Tono K, Kameshima T, Joti Y, Hoshi T.

Rev Sci Instrum. 2013 Sep;84(9):093705. doi: 10.1063/1.4822123.

PMID:
24089834
44.

Maggot debridement therapy for peripheral arterial disease.

Igari K, Toyofuku T, Uchiyama H, Koizumi S, Yonekura K, Kudo T, Jibiki M, Sugano N, Inoue Y.

Ann Vasc Dis. 2013;6(2):145-9. doi: 10.3400/avd.oa.13-00036. Epub 2013 May 30.

45.

[A case report of liver metastasis of breast cancer successfully treated by hepatic arterial infusion of docetaxel and systemic administration of nab-paclitaxel].

Satoh E, Ebuchi M, Maruyama M, Akazawa N, Suzuki K, Uehira D, Ono S, Yonekura K, Murakata A, Tanami H, Maruyama S, Sugano N, Sakoma T.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2066-7. Japanese.

PMID:
23267978
46.

Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.

Sugaya M, Hamada T, Kawai K, Yonekura K, Ohtsuka M, Shimauchi T, Tokura Y, Nozaki K, Izutsu K, Suzuki R, Setoyama M, Nagatani T, Koga H, Tani M, Iwatsuki K.

J Dermatol. 2013 Jan;40(1):2-14. doi: 10.1111/j.1346-8138.2012.01639.x. Epub 2012 Aug 20.

PMID:
22900999
47.

Terahertz wave techniques using a metal mesh for evaluating the components of the stratum corneum.

Mizukoshi K, Yonekura K, Ogura H, Guan Y, Kawase K.

Skin Res Technol. 2013 Feb;19(1):e383-9. doi: 10.1111/j.1600-0846.2012.00655.x. Epub 2012 Jun 5.

PMID:
22672498
48.

Indication for random skin biopsy for the diagnosis of intravascular large B cell lymphoma.

Higashi Y, Kawai K, Yonekura K, Takeda K, Kanzaki T, Utsunomiya A, Kanekura T.

Dermatology. 2012;224(1):46-50. doi: 10.1159/000336885. Epub 2012 Mar 13.

PMID:
22414723
49.

Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.

Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T.

J Dermatol. 2011 Oct;38(10):996-8. doi: 10.1111/j.1346-8138.2010.01149.x. Epub 2011 Feb 1. No abstract available.

PMID:
21972953
50.

A new glycosylated dihydrophaseic acid from cacao germs (Theobroma cacao L.).

Sannohe Y, Gomi S, Murata T, Ohyama M, Yonekura K, Kanegae M, Koga J.

Biosci Biotechnol Biochem. 2011;75(8):1606-7. Epub 2011 Aug 7.

Supplemental Content

Loading ...
Support Center